marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
Fulgent Genetics Balance Sheet 2011-2024 | FLGT
Annual Balance Sheet Fulgent Genetics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-92.8 M | -71.6 M | -162 M | - | -9.29 M | -6.74 M | -6.49 M | -7.9 M | -489 K | -172 K | - | - | - |
Long Term Debt |
760 K | 1.82 M | 1.4 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
3.96 M | 6.13 M | 1.84 M | 267 K | 420 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 2.26 M | 14 K | 6 K | 245 K | - | - | - | - | - |
Total Current Liabilities |
73 M | 88.1 M | 105 M | 130 M | 3.72 M | 2.74 M | 3 M | 3.32 M | - | - | - | - | - |
Total Liabilities |
102 M | 116 M | 113 M | 131 M | 5.98 M | 2.75 M | 3.01 M | 3.56 M | 686 K | 436 K | - | - | - |
Deferred Revenue |
2.87 M | 3.2 M | 14.6 M | 26.6 M | 365 K | - | - | - | - | - | - | - | - |
Retained Earnings |
633 M | 801 M | 658 M | 151 M | -63.4 M | -63 M | -57.7 M | -55.2 M | -53.2 M | -10.3 M | - | - | - |
Total Assets |
1.24 B | 1.39 B | 1.28 B | 700 M | 88.8 M | 53.9 M | 57.2 M | 58 M | 5.83 M | 2.12 M | - | - | - |
Cash and Cash Equivalents |
97.5 M | 79.5 M | 165 M | 87.4 M | 12 M | 6.74 M | 6.49 M | 7.9 M | - | - | - | - | - |
Book Value |
1.13 B | 1.27 B | 1.17 B | 569 M | 82.8 M | 51.2 M | 54.2 M | 54.5 M | 5.15 M | 1.68 M | - | - | - |
Total Shareholders Equity |
1.14 B | 1.27 B | 1.17 B | 569 M | 82.8 M | 51.2 M | 54.2 M | 54.5 M | 5.15 M | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Fulgent Genetics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
448 K | 535 K | 622 K | 760 K | 894 K | 1.03 M | 1.58 M | 1.82 M | 2.05 M | - | 1.31 M | 1.4 M | 31 K | 1.19 M | 499 K | 568 K | 568 K | 568 K | 568 K | 2.26 M | 2.26 M | 2.26 M | 2.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
98.9 M | 103 M | 103 M | 102 M | 96.6 M | 91.3 M | 108 M | 116 M | 124 M | - | 153 M | 113 M | 160 M | 129 M | 198 M | 131 M | 131 M | 131 M | 131 M | 5.98 M | 5.98 M | 5.98 M | 5.98 M | 2.75 M | 2.75 M | 2.75 M | 2.75 M | 3.01 M | 3.01 M | 3.01 M | 3.01 M | 3.56 M | 3.56 M | 3.56 M | 3.56 M | 686 K | 686 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
2.97 M | 2.74 M | 2.76 M | 2.87 M | 2.59 M | 2.6 M | 2.73 M | 3.2 M | 2.6 M | - | 14.1 M | 14.6 M | 7.88 M | 6.92 M | 14 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 365 K | 365 K | 365 K | 365 K | 166 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
596 M | 611 M | 620 M | 633 M | 761 M | 774 M | 786 M | 801 M | 825 M | - | 812 M | 658 M | 553 M | 431 M | 351 M | 151 M | 151 M | 151 M | 151 M | -63.4 M | -63.4 M | -63.4 M | -63.4 M | -63 M | -63 M | -63 M | -63 M | -57.7 M | -57.7 M | -57.7 M | -57.7 M | -55.2 M | -55.2 M | -55.2 M | -55.2 M | -53.2 M | -53.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
1.23 B | 1.23 B | 1.23 B | 1.24 B | 1.36 B | 1.35 B | 1.38 B | 1.39 B | 1.41 B | - | 1.47 B | 1.28 B | 1.2 B | 1.05 B | 999 M | 700 M | 700 M | 700 M | 700 M | 88.8 M | 88.8 M | 88.8 M | 88.8 M | 53.9 M | 53.9 M | 53.9 M | 53.9 M | 57.2 M | 57.2 M | 57.2 M | 57.2 M | 58 M | 58 M | 58 M | 58 M | 5.83 M | 5.83 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
58 M | 65.1 M | 54.7 M | 97.5 M | 84.1 M | 58.3 M | 66.2 M | 79.5 M | 169 M | 139 M | 353 M | 165 M | 215 M | 100 M | 151 M | 87.4 M | 87.4 M | 87.4 M | 87.4 M | 12 M | 12 M | 12 M | 12 M | 6.74 M | 6.74 M | 6.74 M | 6.74 M | 6.49 M | 6.49 M | 6.49 M | 6.49 M | 7.9 M | 7.9 M | 7.9 M | 7.9 M | 489 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
1.13 B | 1.13 B | 1.13 B | 1.13 B | 1.26 B | 1.26 B | 1.27 B | 1.27 B | 1.28 B | - | 1.31 B | 1.17 B | 1.04 B | 921 M | 802 M | 569 M | 569 M | 569 M | 569 M | 82.8 M | 82.8 M | 82.8 M | 82.8 M | 51.2 M | 51.2 M | 51.2 M | 51.2 M | 54.2 M | 54.2 M | 54.2 M | 54.2 M | 54.5 M | 54.5 M | 54.5 M | 54.5 M | 5.15 M | 5.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
1.14 B | 1.13 B | 1.13 B | 1.14 B | 1.26 B | 1.26 B | 1.27 B | 1.27 B | 1.28 B | 1.31 B | 1.31 B | 1.16 B | 1.04 B | 921 M | 802 M | 569 M | 569 M | 569 M | 569 M | 82.8 M | 82.8 M | 82.8 M | 82.8 M | 51.2 M | 51.2 M | 51.2 M | 51.2 M | 54.2 M | 54.2 M | 54.2 M | 54.2 M | 54.5 M | 54.5 M | 54.5 M | 54.5 M | 5.15 M | 5.15 M | - | - | 1.68 M | - | - | - | 1.97 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency